PatientsVille.com LogoPatientsVille.com

Erythema Migrans | Culture Media for Borrelia Burgdorferi Sensu Lato

Erythema Migrans research study

What is the primary objective of this study?

The main purpose of this study is to compare effectiveness of two different culture media for cultivation of Borrelia burgdorferi sensu lato from skin specimens obtained from patients with erythema migrans.

Who is eligible to participate?

Inclusion Criteria: - erythema migrans in patients > 18 years Exclusion Criteria: - pregnancy or lactation - taking antibiotic with antiborrelial activity within 10 days - erythema migrans localized on face or neck Each patient (235 subjects) provided two skin samples (470 skin samples).

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Erythema Migrans

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:MKP mediaone half of skin specimen was put in MKP media

Other:BSK-H mediaone half of skin specimen was put in BSK-H media

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

MKP media versus BSK-H mediaone half of skin specimen obtained from erythema migrans patients was cultivated for Borrelia burgdorferi sensu lato in MKP media and the other half in BSK-H media

Study Status

Completed

Start Date: July 2013

Completed Date:

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Detection of Borrelia Burgdorferi Sensu Lato by Microscopy in Dark Field (Positive vs. Negative)

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Franc Strle, MD, PhD

Lead Sponsor: University Medical Centre Ljubljana

Collaborator: University of Ljubljana School of Medicine, Slovenia

More information:https://clinicaltrials.gov/show/NCT02145754

Discuss Erythema